Preview

National Journal glaucoma

Advanced search
Fullscreen

For citations:


Gusarevich A.A., Zavadski P.C., Kuroyedov A.V., Gazizova I.R., Zvereva O.G., Karimov U.R., Filippov P.G., Diordiichuk S.V., Dorofeev D.A., Kosmynina S.V., Avdeev R.V., Gorodnichii V.V., Zakhidov A.B., Zubasheva S.A., Bakunina N.A., Baryshnikova D.A., Basinskiy A.S., Gabdrakhmanov L.M., Gaponko O.V., Gar’kavenko V.V., Getmanova A.M., Zhavoronkov S.A., Kondrakova I.V., Lanin S.N., Molchanova E.V., Myakonkaya O.S., Rabianok N.A., Razhko Yu.I., Chernyakova T.V., Shakhalova A.P., Iuldashev A.M. The correct choice of monotherapy with prostaglandin analogues/ prostamides at the start of treatment for newly diagnosed glaucoma (results of a multicenter study). National Journal glaucoma. 2020;19(3):43-57. (In Russ.) https://doi.org/10.25700/NJG.2020.03.05



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-4104 (Print)
ISSN 2311-6862 (Online)